HSCA Comments to the U.S. ITC on COVID-19 Related Goods: The U.S. Industry, Market, Trade, and Supply Chain Challenges
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the opportunity to provide comments to the U.S. International Trade Commission (USITC) regarding supply chain challenges related to COVID-19 and critical medical products. HSCA appreciates the Commission’s leadership and efforts to-date to help identify COVID-related materials and goods and increase access to these essential supplies. Through collaboration and efforts to further strengthen supply chain resilience, we can best support our nation’s healthcare providers and overall preparedness. HSCA is committed to supporting patient care and ensuring healthcare providers are equipped to respond to emergencies and public health crises like the COVID-19 pandemic.
Click here to read the full comments.
Related Posts
Comments of the Healthcare Supply Chain Association to FDA on Identifying the Root Causes of Drug Shortages and Finding Enduring Solutions
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the...
HSCA Announces 2019 Board of Directors and Names GNYHA Ventures President Lee Perlman Board Chair
Washington, DC (January, 2019) – The Healthcare Supply Chain Association (HSCA)...
HSCA Names Leading National Healthcare Expert Khatereh Calleja as President & CEO
Washington, DC (April 2, 2019) – The Healthcare Supply Chain Association (HSCA)...
HSCA E&C Letter on Improving Competition in the Generic Marketplace
Dear Chairman Pallone and Ranking Member Walden, I am writing to you on behalf...